Real‐world evaluation of capillary microsampling for drug monitoring of anti‐seizure medications
Chiara Cancellerini, Alice Caravelli, Martina Soldà, Erika Esposito et autres
it (code pays fourni par la source)
0 citations
Epilepsia
Luca Vignatelli
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
229Publications signalées
7712Citations signalées
3Affiliations récentes
Les institutions déclarées
Les domaines associés
Sleep and Wakefulness ResearchEpilepsy research and treatmentSleep and related disordersParkinson's Disease Mechanisms and TreatmentsSleep and Work-Related Fatigue
Les publications récentes
Insomnia as risk factor for brain, mental and general health consequences: an umbrella systematic review
Luca Vignatelli, M. Leone, Elisabetta Pupillo, Stefan Seidel et autres
it, at, de, ch (code pays fourni par la source)
0 citations
Sleep Medicine Reviews
Reply to “Pooling Alzheimer’s disease: when methodological rigor risks obscuring biological complexity”
Francesco Nonino, Luca Vignatelli, Edo Richard
it, nl (code pays fourni par la source)
0 citations
Neurological Sciences
Telemedicine Consultation as Diagnostic Triage for Adult and Children With Suspected Narcolepsy: A Reliability and Diagnostic Accuracy Study
Luca Vignatelli, Fabio Pizza, Stefano Vandi, Flavia Baccari et autres
it (code pays fourni par la source)
0 citations
Journal of Sleep Research
MicroLC-HRMS selective quantification of a biotherapeutic fusion protein in plasma and cerebrospinal fluid of patients with Lafora disease using a linker-containing signature peptide
Erika Esposito, Alice Caravelli, Lorenzo Muccioli, Chiara Cancellerini et autres
it (code pays fourni par la source)
0 citations
Journal of Pharmaceutical and Biomedical Analysis
The Italian registry for narcolepsy and central disorders of hypersomnolence (ReN&IS): Baseline clinical and diagnostic findings
Paola Torreri, G. Buoncuore, Adele Rocchetti, Lorenzo Facciaroni et autres
it, cl, us (code pays fourni par la source)
1 citation
Sleep Medicine
Amyloid-beta-targeting monoclonal antibodies for people with mild cognitive impairment or mild dementia due to Alzheimer’s disease
Francesco Nonino, Silvia Minozzi, L. Sambati, Cinzia Del Giovane et autres
it, ch, nl (code pays fourni par la source)
25 citations
Cochrane Database of Systematic Reviews
Amyloid-beta-targeting monoclonal antibodies for people with mild cognitive impairment or mild dementia due to Alzheimer's disease.
Francesco Nonino, Silvia Minozzi, Luisa Sambati, Cinzia Del Giovane et autres
qa (code pays fourni par la source)
0 citations
Open Access CRIS of the University of Bern
New therapeutic strategies for Lafora disease: Evaluation of the safety, efficacy, pharmacokinetics and metabolomic profile of intravenous VAL-1221 treatment
Lorenzo Muccioli, Maria Tappatà, Andrea Farolfi, Pankaj K. Singh et autres
it, us (code pays fourni par la source)
1 citation
Neurotherapeutics
Quality of life and disability in pure autonomic failure: More than a prodromal synucleinopathy
Ilaria Cani, Giannicola Carrozzo, Flavia Baccari, Martino Schettino et autres
it (code pays fourni par la source)
0 citations
Parkinsonism & Related Disorders
Assessment of the potential use of VAL-1221 for Lafora disease: MS-based proteomics for the characterization and quantitation of the biotechnological drug in plasma and cerebrospinal fluid
Erika Esposito, Alice Caravelli, Lorenzo Muccioli, Chiara Cancellerini et autres
it, in (code pays fourni par la source)
0 citations
medRxiv
Hypertension, Diabetes and Depression as Modifiable Risk Factors for Dementia: A Common Data Model Approach in a Population-Based Cohort, with Study Protocol and Preliminary Results
Corrado Zenesini, Silvia Cascini, Roberta Picariello, Francesco Profili et autres
it (code pays fourni par la source)
0 citations
Journal of Clinical Medicine
BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.